From: Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19)
Assumed true prevalence of SARS-CoV-2 seropositive residents of Munich (1.5 million inhabitants) | 95% Confidence Interval of SARS-CoV-2 seropositive participants in KoCo19 (N=4,500) |
---|---|
0.5% | 0.31% - 0.71% |
1% | 0.71% - 1.29% |
5% | 4.38% - 5.64% |
10% | 9.13% - 10.89% |
20% | 18.84% - 21.18% |
30% | 28.67% - 31.31% |
50% | 48.56% - 51.47% |